ro retatrutide 💉 is the most powerful weight loss drug ever trialled. 28.7 percent average body weight loss in 68 weeks. Some participants lost over 30 percent of their starting body weight. The Retatrutide Phase 3: 60% Achieved

Stopping CPAP without confirming OSA resolution leaves you exposed to the cardiovascular risks of untreated disease

Our findings confer with current (year 2023) practical guidelines of European Society of Cardiology (ESC) for the management of CV disease in patients with diabetes (105) provide a list of medication deleterious for HF prognosis, including several agents used to treat T2DM

furthermore, weight loss of 5% to 19% of body weight, depending on the agent, has been documented

In contrast, chronic daily central treatment with the Ex-4 does not affect anxiety-like behavior but instead reduces depression-like behavior in the force swim test (FST) [117]